If you would like to submit a blog post for consideration, please email admin@healthcert.com

Anti-Ageing Supplement Rejuvenates Sun Damaged Skin

Anti-aging Skin Care

A clinical trial in Texas sought to evaluate the effectiveness of an oral anti-ageing supplement in treating sun damaged skin, and found it be effective in significantly improving the appearance of facial photoaging. The signs of skin ageing – including the development of fine lines, wrinkles and discolouration – are the result of both intrinsic and […]

Ageing Differences in Ethnic Skin

Ageing Differences in Ethnic Skin

Do different skin types age differently? A recent study sought to discover the differences in the ageing process in skin of varying ethnicities, and found that the effects of ageing are often varied based on ethnic origin. Specifically, it determined that people with darker skin appear younger because they have firmer and smoother skin than […]

Dermatology Research review

Dermatology written on a clipboard

A phase two trial from a recent issue of N Engl J Med reports that selective IL-23 blockade with risankizumab provides better clinical responses than ustekinumab for the treatment of moderate-to-severe plaque psoriasis. Four other papers also focus on psoriasis, including a meta-analysis of the risk of major adverse CV events associated with the use of […]

Management guidelines for Retinal Vein Occlusion

Retinal Vein Occlusion

A 55-year-old, generally healthy man with a history of migraines presents with blurred vision he has had for a few days. What is your diagnosis? In the short video below you will learn about:

Monthly Dermatology Review: Special Edition on Acne

acne-1606765_1920

It is interesting to note that in this month’s review of acne journal articles there were certain trends such as the use of light and lasers, revisiting well-established treatments such as oral antibiotics and spironolactone as well as those studies supporting new treatments. Several new topical treatments are now or soon to be available. The […]

Consensus on the practical use of incobotulinumtoxinA

Consensus on the practical use of incobotulinumtoxinA

In 2015, botulinum toxin type A (BTX-A) was the most frequently delivered minimally-invasive cosmetic procedure, with over 6.7 million mediated aesthetic interventions performed. The United States Food and Drug Administration (FDA) approved BTX-A in aesthetic medical use for the treatment of glabella lines and lateral canthal rhytides. It is also approved in Australia and New […]

Updated global guidelines for the diagnosis, classification and assessment of rosacea

Updated global guidelines for the diagnosis, classification and assessment of rosacea

Rosacea is currently diagnosed by consensus-defined primary and secondary features and managed by subtype. However, individual features can span multiple subtypes, which has implications for clinical practice and research. Adopting a phenotype-led approach may help patient-centred management. Seventeen dermatologists and three ophthalmologists used a modified Delphi approach to reach consensus on statements regarding aspects of […]

WHO guidelines for prevention of surgical site infection

WHO guidelines for prevention of surgical site infection

The World Health Organization (WHO) has released their first-ever global guidelines for the prevention of surgical site infection. The Australasian Journal of Dermatology is cited as a reference in the guidelines with a paper on Mohs surgery by Tai et al. The guidelines include a list of 29 recommendations designed to address the increasing burden […]

What’s new in atopic eczema?

What’s new in atopic eczema?

This review, which is part of a series of annual updates on the evidence base for atopic eczema, highlighted key findings from 12 systematic reviews from 2014 focusing on treatment and prevention. It shows the difficulty in effectively treating atopic eczema. Although cyclosporin, azathioprine and methotrexate are commonly used to treat atopic eczema, evidence supporting […]

[May] Research review on Psoriasis

Dermatology corner image

A couple of papers in this issue highlight the increased risk of malignancy associated with psoriasis. The findings illustrate an increased risk of melanoma and haematological cancers in patients with psoriasis compared with the general population. Notably, this risk is not increased by systemic or biologic psoriasis therapies.

Subscribe